little green pharmashttps://www.sydneycriminallawyers.com.au/blog/australias-first-cannabis-medicine-an-interview-with-little-green-pharmas-fleta-solomon/
We have a requirement to look after Australian patients. And as you’ve mentioned earlier, there are probably many patients at the moment who can’t actually access cannabis in Australia. And you’re correct. I think there’s just over 1,200 patients.
What we’ll find is that as doctors become educated that that number will start to increase.
Our vision from the very beginning was we want to help as many people as we can and there’s thousands across the world. And so, we are going set up our facility and expand our operation to accommodate the thousands of people that we can actually help and benefit from cannabinoid therapy.
We are looking to export excess product through overseas markets, such as Germany, where millions of people are actually waiting for cannabinoid therapy.